Edmund Harrigan, Director at Karuna Therapeutics, Inc. (KRTX), sold 30,000 shares at $91.79 ($2.8M) on 2020-06-12, disclosed to the SEC on 2020-06-15.
Open-market sale of $2.8M KRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| KRTX | SELL | 2020-07-13 | $934K | — | Filing → |
| ACAD | BUY | 2016-08-18 | $33K | — | Filing → |